Drug intelligence / Profile preview

Taxadrol

Development stage
Unknown
Lead developer
All American Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Taxadrol is a natural testosterone-boosting nutraceutical developed by Dr. Jeff Golini and manufactured by All American Pharmaceutical. It is a non-prohormone, non-steroidal supplement derived from a proprietary whole-plant extract of a specific Montana pine species (*Pinus silvestris*). The extract contains a complex mixture of flavonoids, terpenoids, and phytosterols. Taxadrol's biological mechanism involves stimulating the body's endogenous production of testosterone and increasing free testosterone levels while simultaneously functioning as an anti-aromatase agent to inhibit the conversion of testosterone into estrogen. It is primarily indicated for sports nutrition and athletic performance enhancement, targeting muscle building, strength increases, and the management of testosterone deficiency in athletes and older men. Preclinical and human case studies have demonstrated significant increases in testosterone levels without reported toxicity or major side effects.

Brand names
Taxadrol
Other names
Pinus silvestris extract
02

Targets

CYP19A1 (Aromatase)

Beyond the preview

Go deeper on Taxadrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taxadrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call